Combo Therapies Tested to Overcome Drug Resistance in Melanoma Patients
Tuesday, August 2, 2011 - 08:30
in Health & Medicine
Scientists at UCLA's Jonsson Comprehensive Cancer Center tested a combination of small molecules that may, when used with the BRAF inhibitors, help overcome this drug resistance and extend the lives of those with advanced melanoma.
